FinDogFinDog
Wednesday, September 16, 2026Closing data · 4:00 PM ET
English
Log in

VEEV

Veeva SystemsNYSE · Health Care Technology · Health Care
Previous close
264.90
Change
−1.72 / −0.65%
FinDog View
Bullish
52-Week Range
148.05 – 310.50
P/E (TTM)
42.5
Forward P/E
28.7
Based on consensus earnings for the next 12 months
Market Cap
$42.9B
1M
+11.14%
S&P 500 −2.41% over same period
Volume / Avg Volume
1.1M / 1.2M
0.91× average

Price History

Closing price · USD1M6M1Y5Y
150200250300FY27 Q2 EarningsFY27 Q1 Earnings2026-032026-052026-062026-082026-09

Historical P/E

Close ÷ trailing four-quarter EPS · Period median 32.71M6M1Y5Y
20304050602026-032026-052026-062026-082026-09

Recent Earnings

Click to read the FinDog analysis
PeriodReportedRevenueEPS Actual / Est.Next-Day MoveAnalysis
FY2027 Q2
Quarter ended 2026-07
2026-08-26$928M2.35 / —+15.20%Read analysis →
FY2027 Q1
Quarter ended 2026-04
2026-06-03$883M2.24 / —−0.07%Pending
FY2026 Q4
Quarter ended 2026-01
2026-03-04—— / —+4.02%Pending
FY2026 Q3
Quarter ended 2025-10
2025-11-20—— / —−9.77%Pending
FY2026 Q2
Quarter ended 2025-07
2025-08-27—— / —−7.24%Pending
FY2026 Q1
Quarter ended 2025-04
2025-05-28—— / —+19.00%Pending

Decision Panel

Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market data
Valuation
P/E is at percentile 19 of its 5-year rangeCheap
5-year range 30.6 – 65.5 · Median 55.9
Last 4 quarters: $473M in buybacks + $0 in dividends, 1.10% of market cap combined
P/E (TTM)
42.5
P/B
5.8
P/S
12.5
PEG
1.78
Earnings Reaction
Over the last 6 reports, the stock moved ±9.2% on average on the first trading day after, rising 3 times
Most recent +15.20%
Volatility & Correlation
1-year beta 0.35 · Correlation with S&P 500 0.10Low beta
Annualized volatility 49% vs. 14% for the S&P 500
Insider Trading
View all →
Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 5 · $13.3MNet selling $13.3M
  • 09-14Schwenger Thomas D.Pres. & Chief Customer OfficerSell$0.27M1,000 shares · Avg price 265.20
  • 09-09Hung PriscillaDirectorSell$0.20M750 shares · Avg price 261.04
  • 08-27Schwenger Thomas D.Pres. & Chief Customer OfficerSell$2.8M10,000 shares · Avg price 281.33
  • 08-13Schwenger Thomas D.Pres. & Chief Customer OfficerSell$9.0M36,000 shares · 3 trades · Avg price 250.23
  • 07-16Schwenger Thomas D.Pres. & Chief Customer OfficerSell$1.0M5,000 shares · Avg price 200.00
Multi-Quarter Financial Trends
View all quarters →
Last 12 quarters · As reported by the company
QuarterRevenue ($B)YoYGross MarginOperating Income ($B)Net Income ($B)Free Cash Flow ($B)EPS
FY2027 Q20.93+17.6%75.0%0.280.270.241.66
FY2027 Q10.88+16.3%75.0%0.270.261.131.57
FY2026 Q40.84+16.0%74.5%0.250.240.111.48
FY2026 Q30.81+16.0%75.4%0.240.240.191.40
FY2026 Q20.79+16.7%75.3%0.200.200.241.19
FY2026 Q10.76+16.7%77.1%0.230.230.881.37
FY2025 Q40.72+14.3%74.9%0.190.200.071.17
FY2025 Q30.70+13.4%75.1%0.180.190.161.13
FY2025 Q20.68+14.6%74.8%0.170.170.091.04
FY2025 Q10.65+23.6%73.3%0.160.160.760.98
FY2024 Q40.63+11.9%72.4%0.140.150.060.90
FY2024 Q30.62+11.6%72.8%0.130.140.080.83

Peers

Largest by market cap in the sector · Latest quarterView Health Care sector →
TickerCompanyMarket CapP/ERevenue YoYGross Margin1MView
VEEVVeeva Systems$42.9B42.5+17.6%75.0%+11.14%Bullish
LLYLilly (Eli)$1.07T39.9+47.7%85.8%−3.83%BullishCompare
JNJJohnson & Johnson$644B30.6+6.6%68.2%+1.87%BullishCompare
ABBVAbbVie$464B73.7+10.2%74.7%+4.87%NeutralCompare
MRKMerck & Co.$358B112.2+5.1%73.5%+6.57%NeutralCompare
UNHUnitedHealth Group$337B23.9+0.4%88.1%−5.15%NeutralCompare
TMOThermo Fisher Scientific$240B34.4+10.5%—+10.75%BullishCompare
AMGNAmgen$203B23.3+9.5%72.0%−10.26%NeutralCompare
GILDGilead Sciences$183B—+10.2%79.8%+6.31%NeutralCompare